GL
Global Life Science Ventures
Venture CapitalActiveGlobal Life Science Ventures is a swiss investment fund focusing exclusively on the life sciences sector.
30
Investments
4
Exits
€600M
AUM
13.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Global Life Science Ventures.
Investment Thesis & Strategy
Global Life Science Ventures invests in life science companies across various stages, leveraging its Swiss base to identify and support innovative ventures within the sector.
Investment Activity
Deals per year over the last 20 years
1
20040
20051
20061
20070
20080
20091
20100
20110
20120
20131
20141
20150
20160
20170
20181
20190
20202
20211
20221
2023Portfolio Companies
Selected investments from their portfolio of 30 companies
T
TRIALSSITE
Healthcare · Seed, 2023
N
Neuronyx
Biotech · Series A, 2022
G
GlycoEra
Biotech · Series A, 2021
G
GeneQuine
Biotech · Series A, 2021
T
T3 Pharmaceuticals
Biotech · Series A, 2019
O
ObsEva
Biotech · Series C+, 2015
A
AM-Pharma
Biotech · Series C+, 2014
I
InSphero
Biotech · Growth, 2010
N
NovImmune
Biotech · Growth, 2007
M
Molecular Partners
Biotech · Growth, 2006
S
Santhera Pharmaceuticals
Biotech · Growth, 2004
Notable Exits
CompanyTypeYearValue / Acquirer
BiotestAcquisition2020—
InflaRxIPO2017—
SuppremolAcquisition2016—
4SCIPO2005—
Frequently Asked Questions
Global Life Science Ventures focuses on Series A, Series B, Series C+ stage investments.